GAVI, the Vaccine Alliance, which was co-founded by Bill Gates in 2000, has secured a record cost-cutting vaccine deal, the organization announced today.
This will ensure sufficient supplies for the next three years to protect millions of children in GAVI-supported and transitioning countries. Moreover, pentavalent vaccine – a cornerstone of routine immunization programs – will be accessible from a broad base of manufacturers at less than $1: half this year’s average price.
“We estimate that pentavalent vaccination will avert 5.7 million deaths in GAVI-supported countries between 2011 and 2020,” said Dr Seth Berkley, chief executive of GAVI. “The market for five-in-one vaccines is now a lot healthier than it was just a few years ago thanks to our collective efforts to grow a base of vaccine suppliers. We remain committed to making vaccine markets work better for the world’s poorest countries to ensure immunization investments and efforts are sustainable for all,” he noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze